Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

Overview of attention for article published in Journal of Hepatocellular Carcinoma, September 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

googleplus: 1 Google+ user

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 22 Mendeley

Summary Google+ Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Article in Journal of Hepatocellular Carcinoma (March 2024)

Ghrelin regulating liver activity and its potential effects on liver fibrosis and Echinococcosis

Article in Frontiers in Cellular and Infection Microbiology (January 2024)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights

Article in Journal of Hepatocellular Carcinoma (July 2023)